| pubmed-article:11505018 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11505018 | lifeskim:mentions | umls-concept:C0687669 | lld:lifeskim |
| pubmed-article:11505018 | lifeskim:mentions | umls-concept:C0004927 | lld:lifeskim |
| pubmed-article:11505018 | lifeskim:mentions | umls-concept:C0170657 | lld:lifeskim |
| pubmed-article:11505018 | lifeskim:mentions | umls-concept:C0001721 | lld:lifeskim |
| pubmed-article:11505018 | lifeskim:mentions | umls-concept:C0017431 | lld:lifeskim |
| pubmed-article:11505018 | lifeskim:mentions | umls-concept:C0205160 | lld:lifeskim |
| pubmed-article:11505018 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:11505018 | lifeskim:mentions | umls-concept:C0424296 | lld:lifeskim |
| pubmed-article:11505018 | lifeskim:mentions | umls-concept:C0234410 | lld:lifeskim |
| pubmed-article:11505018 | lifeskim:mentions | umls-concept:C0086860 | lld:lifeskim |
| pubmed-article:11505018 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:11505018 | lifeskim:mentions | umls-concept:C1555903 | lld:lifeskim |
| pubmed-article:11505018 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:11505018 | pubmed:dateCreated | 2001-8-15 | lld:pubmed |
| pubmed-article:11505018 | pubmed:abstractText | Serotonergic (5-HT) dysfunction has been implicated in the etiology of both behavioral disinhibition (BD) and negative affect (NA). This work extends our previous finding of relationships between whole blood 5-HT and both BD and NA in pubescent, but not prepubescent, children of alcoholics and continues examination of a hypothesized role of 5-HT dysfunction in alcoholism risk. The long and short (L and S) variants of the 5-HT transporter gene-linked polymorphic region (5-HTTLPR) are responsible for differing transcriptional efficiencies in 5-HT uptake. Although associations have been found between the SS 5-HTTLPR genotype and severe alcoholism and neuroticism, recent reports describe relationships between the LL genotype and both low level of response to alcohol and alcoholism diagnosis and a predominance of the LL genotype in early-onset alcoholics. | lld:pubmed |
| pubmed-article:11505018 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11505018 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11505018 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11505018 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11505018 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11505018 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11505018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11505018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11505018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11505018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11505018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11505018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11505018 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11505018 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:11505018 | pubmed:issn | 0145-6008 | lld:pubmed |
| pubmed-article:11505018 | pubmed:author | pubmed-author:CookE HEH | lld:pubmed |
| pubmed-article:11505018 | pubmed:author | pubmed-author:ZuckerR ARA | lld:pubmed |
| pubmed-article:11505018 | pubmed:author | pubmed-author:TwitchellG... | lld:pubmed |
| pubmed-article:11505018 | pubmed:author | pubmed-author:HannaG LGL | lld:pubmed |
| pubmed-article:11505018 | pubmed:author | pubmed-author:StoltenbergS... | lld:pubmed |
| pubmed-article:11505018 | pubmed:author | pubmed-author:Fitzgerald... | lld:pubmed |
| pubmed-article:11505018 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11505018 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:11505018 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11505018 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11505018 | pubmed:pagination | 953-9 | lld:pubmed |
| pubmed-article:11505018 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:meshHeading | pubmed-meshheading:11505018... | lld:pubmed |
| pubmed-article:11505018 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11505018 | pubmed:articleTitle | Serotonin transporter promoter polymorphism genotype is associated with behavioral disinhibition and negative affect in children of alcoholics. | lld:pubmed |
| pubmed-article:11505018 | pubmed:affiliation | Integrated Substance Abuse Programs (GRT), University of California, Los Angeles, California 90025, USA. twitche2@ucla.edu | lld:pubmed |
| pubmed-article:11505018 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11505018 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11505018 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:11505018 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11505018 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11505018 | lld:pubmed |
